JJ
Johnson & Johnson
JNJ
NYSEHealth Care
$230.60
USD
+3.25(+1.43%)
At close: Apr 30, 14:23 UTC
Loading chart…
Open
$230.65
Prev. Close
$230.72
High
$230.86
Low
$230.60
Market Snapshot
Market Cap
$547.89B
P/E Ratio
26.0
EPS
5.84
Revenue
$88.82B
About
The company is headquartered in New Brunswick, New Jersey and currently employs 138,200 full-time employees.
Why JNJ moved
Johnson & Johnson's FDA approval of IMAAVY and CAPLYTA boosts its growth prospects in immunology and neuropsychiatry, strengthening its position in these competitive sectors.
About
The company is headquartered in New Brunswick, New Jersey and currently employs 138,200 full-time employees.
Recently from Cashu
Johnson & Johnson Expands MedTech Reach with Atraverse Acquisition and Viz.ai Partnership
Cashu Markets·4d ago
Johnson & Johnson Advances Myasthenia Gravis Treatment with Promising IMAAVY Study Results
Cashu Markets·8 days ago
Johnson & Johnson Exceeds Earnings Expectations, Raises Full-Year Sales Forecast Amid Strong Performance
Cashu Markets·15 days ago
Johnson & Johnson Partners with GI Innovation for Advanced Prostate Cancer Treatment Trial
Cashu Markets·1 month ago